We use cookies to improve your experience on this website.

News & Events

Upcoming- DPS Group Participation in an ISPE Boston Area Chapter Panel Discussion

Tuesday 04 December 2018

John Dougherty, principal process engineer at DPS Group, will participate in an ISPE Boston Area Chapter panel discussion on “Designing, Building & Operating Manufacturing Facilities for Novel Therapeutics” on December 6, 2018, moderated by Jeff Kent, process engineer at DPS Group.  Dougherty will be joined by panelist, Lance Weed, Principal Consultant, and others to be announced.

Sponsored by the ISPE Boston Chapter, the education session will focus on the design of manufacturing facilities for the production of novel therapeutics, which requires careful planning and consideration of a myriad of factors such as throughput, biosafety level, product segregation and contamination control, regulatory environment, time to market, and tech transfer challenges. It is a complex mix of elements, and requires a project team that can move quickly and effectively to de-risk the investment and meet market demand. Recently, many firms have embarked on ambitious program to bring manufacturing capacity for gene and cell therapies online to meet demand for novel therapeutics.

The education session will cover planning, design, quality/regulatory considerations, and technology platforms utilized in the design of manufacturing facilities for the production of novel therapeutics.

Where

Novartis Institutes for Biomedical Research
250 Massachusetts Avenue
Cambridge, MA 02139

When

Thursday, December 6, 2018
5:30 pm to 8:30 pm
To register for this event, click here

Who

John Dougherty, Principal Process Engineer, DPS Group

John Dougherty is a highly experienced bioprocess engineer and biologics SME with extensive experience in engineering and project management facility designs for biologics and gene therapy facilities. As a lead process engineer at DPS, he is a collaborative change leader and talent developer delivering results in LEAN manufacturing implementation and Root Cause Analysis. John is also a very strong team builder experienced in project development and implementation for capital projects, as well as continuous improvement teams.  He has a solid background in cGMP, demonstrated performance with regulatory authorities and inspections, and extensive experience in applied design, operation, maintenance, environmental monitoring, and gowning for clean rooms, and holds a LEAN Six Sigma Green Belt. Prior to DPS John held roles such as Head of Technical Operations at Acambis, MA and Director of Manufacturing at Astra Zeneca in Westborough, MA. John is a graduate of Drexel University and an active member of International Society of Pharmaceutical Engineers (ISPE).

 

Jeff Kent, Process Engineer, DPS Group

Jeff Kent is an experienced process engineer with a strong foundation in chemical/biochemical engineering principles and excellent problem solving and analytical skills. Jeff has worked in a broad range of functions in the biotech sector and offers proven abilities in operating/maintaining cGMP purification equipment for commercial manufacturing, selecting and developing primary human cell lines for an R&D laboratory and designing experiments with small-scale bioreactors in support of pharmaceutical cell culture development.  Jeff earned his MS, Chemical Engineering from Northeastern University, BS, Biochemical Engineering, Queen’s University, Canada and BS, Chemical Engineering, Queen’s University, Canada. He is an active member of the American Institute of Engineers and the International Society of Pharmaceutical Engineers (ISPE) Boston Chapter. 

Back to top